Targazyme

Targazyme is a biotechnology company focused on improving survival and quality of life for cancer patients using stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy.

Overview Structured Data Issues Contributors

targazyme.com

Is a

Company

Organization

Company attributes

Industry

Cancer immunotherapy

Biomedical engineering

...

Location

B2X

Founder

AngelList URL

Pitchbook URL

pitchbook.com/profiles.../63633-34

Date Incorporated

2005

Number of Employees (Ranges)

1 – 100

Email Address

Founded Date

2008

Total Funding Amount (USD)

2,500,000

Latest Funding Round Date

July 15, 2009

Wellfound ID

targazyme

Country

United States

Other attributes

Company Operating Status

Active

Wikidata ID

Q30283784

Targazyme is a biotechnology company headquartered in Carlsbad, California and founded by Lynnet Koh in 2005 . The company develops stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy products for treating cancer.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

America Stem Cell, Inc. Changes Its Name to Targazyme, Inc.

Business Wire

https://www.businesswire.com/news/home/20131218005397/en/America-Stem-Cell-Targazyme

Web

Targazyme, Fucosylation Technology Platform

https://www.youtube.com/watch?v=MaR1zN5pdjo

October 27, 2013

References

Find more companies like Targazyme

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.